A closed-loop insulin delivery system helped pregnant women with type 1 diabetes stay in target glucose range, the randomized CIRCUIT trial showed. Among 91 women, those who used a closed-loop insulin ...
Young children using the t:slim X2 insulin pump with Control-IQ Technology system maintained target glucose levels for 3 hours longer than children using an insulin pump or daily injections with a ...
Hosted on MSN
Closed-loop insulin system improves glucose control during pregnancy, clinical trial finds
Previous studies outside of pregnancy have found that closed-loop insulin systems reduce hyperglycemia and hypoglycemia. In a closed-loop insulin system, there is an automated insulin-delivery setup ...
Adults with type 1 diabetes had an increase in total daily insulin dose and bolus insulin dose shortly after stopping ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...
The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...
Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; however, its efficacy is unclear. In this multicenter, controlled trial, we randomly assigned ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the Medtronic MiniMed 780G system for people with type 1 diabetes aged 7 years and older. The ...
Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...
Add Yahoo as a preferred source to see more of our stories on Google. Insulet reported data Wednesday on a fully closed-loop automated insulin delivery system in people with Type 2 diabetes. The 24 ...
A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced hypoglycemia from 4.01% to 0.52% in diabetic rats. (Nanowerk Spotlight) An ...
Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results